Related Experiment Video
Updated: Jul 7, 2026

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
Ensuring the safety of botanical dietary supplements
Richard B van Breemen1, Harry Hs Fong, Norman R Farnsworth
1University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, L 60612, USA. breemen@uic.edu
Abstract:
Botanical dietary supplements with a history of safe human use may not require the same level of toxicity testing as synthetic pharmaceutical drugs. Most of the documented examples of acute toxicity caused by botanical dietary supplements have been caused by the substitution of toxic plants for the desired species, probably through misidentification or production errors, or by contamination with pharmaceutical agents, either as a result of poor manufacturing practices or adulteration. Although more difficult to document, chronic toxicities attributed to botanical dietary supplements may be caused by contamination by heavy metals, pesticides, or microbes or by inherent properties of constituents of the botanicals themselves. Like drug-drug interactions, botanical-drug interactions can also be a source of toxicity. Most of these toxicity problems may be prevented by implementing good agricultural practices and good manufacturing practices and applying existing toxicity testing similar to those used in drug development or new toxicity assays under development based on proteomics, genomics, or metabolomics.
Related Concept Videos
Drug Regulation
Good Manufacturing Practices
Pharmaceutical Poisoning: Potential Scenarios
Sources of Food Contamination
Clinically Relevant Drug Product Specifications: Methods of Establishment
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
